VIVS - VivoSim Labs Inc Sales Growth YoY (Last 12 Months)

Brandmark of VivoSim Labs Inc (VIVS)

Despite external geopolitical uncertainty, VivoSim Labs Inc (VIVS) operates within a secure US legal framework. The rolling annual sales growth trend visualizes revenue dynamics, where -3.50 shows the current value of the metric. Stability is confirmed by transparent management protecting patents, while the implementation of industrial robotics in bioprinting eliminates manual labor errors, guaranteeing the precision accuracy of samples.

Sales Growth YoY (TTM): Organovo Holdings Inc. (VIVS) for 11/23/2025 - 11/18/2026

Summary analytical data breakdowns for Organovo (VIVS)

- market value and analyst target forecast:
Fundamental company valuation:Organovo Holdings, Inc.
Original product of organovo.com

This indicator measures business expansion rates by comparing current trailing twelve-month revenue with the same period last year to filter out short-term fluctuations. By analyzing the annual revenue growth trend over the TTM period, an investor can assess the viability of VivoSim Labs Inc. (VIVS) given the company's critical dependence on the narrow 3D bioprinting segment and a lack of market diversification.

Who VivoSim Labs Inc competes with